West Pharmaceutical Services Inc
NYSE:WST
West Pharmaceutical Services Inc
Net Income (Common)
West Pharmaceutical Services Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
West Pharmaceutical Services Inc
NYSE:WST
|
Net Income (Common)
$568.7m
|
CAGR 3-Years
10%
|
CAGR 5-Years
21%
|
CAGR 10-Years
18%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Net Income (Common)
$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
Danaher Corp
NYSE:DHR
|
Net Income (Common)
$8.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
27%
|
CAGR 10-Years
12%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Net Income (Common)
$788.8m
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
Agilent Technologies Inc
NYSE:A
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Net Income (Common)
$1.4B
|
CAGR 3-Years
69%
|
CAGR 5-Years
39%
|
CAGR 10-Years
20%
|
See Also
What is West Pharmaceutical Services Inc's Net Income (Common)?
Net Income (Common)
568.7m
USD
Based on the financial report for Mar 31, 2024, West Pharmaceutical Services Inc's Net Income (Common) amounts to 568.7m USD.
What is West Pharmaceutical Services Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
18%
Over the last year, the Net Income (Common) growth was 3%. The average annual Net Income (Common) growth rates for West Pharmaceutical Services Inc have been 10% over the past three years , 21% over the past five years , and 18% over the past ten years .